Aussie Oncologists Say Trial Trend Makes Treatments Costlier
This article was originally published in PharmAsia News
Executive Summary
Australian oncologists are calling for independent research of cancer drugs to guard against overuse of expensive ones and those more toxic. The physicians wrote in a professional journal that clinical trials have shifted to testing how long drugs could be tolerated and away from using them until maximum response is determined and then halting their use to avoid toxicity. Their article in The Medical Journal of Australia said that shift toward longer use is not supported by survival or quality-of-life data, making treatment potentially much costlier. (Click here for more